Clare Market Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,490
| Closed | -$600K | – | 159 |
|
|
2024
Q4 | $600K | Sell |
1,490
-140
| -9% | -$56.4K | 0.14% | 84 |
|
|
2024
Q3 | $758K | Buy |
+1,630
| New | +$758K | 0.2% | 65 |
|
|
2022
Q4 | – | Sell |
-735
| Closed | -$213K | – | 144 |
|
|
2022
Q3 | $213K | Buy |
+735
| New | +$213K | 0.09% | 119 |
|
|
2022
Q2 | – | Sell |
-1,375
| Closed | -$359K | – | 174 |
|
|
2022
Q1 | $359K | Buy |
+1,375
| New | +$359K | 0.11% | 109 |
|
|
2020
Q4 | – | Sell |
-820
| Closed | -$223K | – | 134 |
|
|
2020
Q3 | $223K | Sell |
820
-630
| -43% | -$171K | 0.11% | 99 |
|
|
2020
Q2 | $421K | Buy |
+1,450
| New | +$421K | 0.25% | 52 |
|